Clinical Comparison
HIFU is a treatment category; Ultherapy is a named MFU-V platform. Compare exact devices, imaging and treatment depth, evidence limits, risks, and Seoul quotes.
In This Guide
HIFU is a treatment category; Ultherapy is a named MFU-V platform. Compare exact devices, imaging and treatment depth, evidence limits, risks, and Seoul quotes.
Section 1 / 7
HIFU is a category of focused-ultrasound systems, not one interchangeable device. Ultherapy is a named MFU-V platform with integrated ultrasound visualization. The US FDA 510(k) record K233996 identifies the Ulthera System (UC-1 Control Unit PRIME). It does not establish the identity, authorization, evidence, or performance of every device marketed as HIFU.
| Question | HIFU category | Named Ulthera System |
|---|---|---|
| Identity | Multiple manufacturers and models | Named platform and transducers |
| Visualization | Varies by exact model | Integrated imaging to support coupling and depth confirmation |
| Regulatory record | Verify manufacturer, model, jurisdiction, record number, and scope | K233996 is a US model-specific 510(k) record |
| Evidence | Use studies that identify the device and protocol | Use studies and labeling for the named platform |
| Schedule and price | Neither is fixed by a category or brand name. Compare the assessed area, exact device, planned cartridges or treatment lines, clinician, inclusions, and follow-up. | |
Section 2 / 7
The current US Ultherapy PRIME Instructions for Use lists an imaging range from the skin surface to 8 mm. Its face-and-neck treatment transducers have focal depths of 1.5, 3.0, or 4.5 mm. The 0–8 mm number describes the displayed imaging window; it does not mean the whole window is treated.
The IFU and K233996 summary state that imaging is used to check transducer coupling and confirm an appropriate treatment depth, including avoiding bone. They do not describe the image as a map that identifies every nerve or blood vessel, or as a predictor of an individual's cosmetic result.
Section 3 / 7
The Classys product page identifies Ultraformer MPT as a HIFU platform. It lists face cartridges at 1.5, 2.0, 3.0, and 4.5 mm, and describes both normal mode, which places energy in a dot pattern, and MP mode, which applies broader heating across the treatment zone. These are manufacturer specifications, not proof that one platform produces a better clinical result than another.
A 2024 Ultraformer MPT study (PMID 39372881) measured lifting across seven facial units in 50 patients using three-dimensional scans. It was a single cohort with measurements taken before and immediately after treatment. It had no Ultherapy comparison group and does not establish comparative superiority or how long an individual result will last.
Section 4 / 7
No published head-to-head randomized trial establishes a universal winner between Ultherapy and every Korean HIFU model. Separate studies use different devices, settings, populations, endpoints, and follow-up windows, so their results should not be transferred across models as if the systems were equivalent.
The available sources also do not create one fixed session count, maintenance interval, pain score, session duration, or outcome for every face. A useful assessment should identify the concern, anatomy, treatment area, exact platform, planned settings, limitations, alternatives, and reasons to defer treatment.
Section 5 / 7
The Ultherapy PRIME IFU lists redness, swelling, welting, pain or tenderness, bruising, transient nerve effects, and the possibility of burns or scarring if incorrect technique is used. That is device labeling for the named Ulthera System; it should not be copied to every HIFU device as if all models shared one risk profile. Request the exact device's current labeling, material risks, and written aftercare rather than relying on a category-level promise of “no downtime.”
For travel, leave room for individual recovery and a way to contact the treating clinic if symptoms are marked or persistent. Share your preferred consultation language and travel dates when contacting the clinic, and use the international-patient information page to organize communication and follow-up questions.
Section 6 / 7
Request the manufacturer and exact model, treatment area, cartridge depths or treatment-line plan, clinician, pain-control plan, tax, included aftercare, and follow-up in writing. Verify each regulatory statement by jurisdiction and record number; do not infer Korean authorization from a US FDA record, or US FDA status from Korean availability.
Use the current pricing page for Delight's published ranges. This guide intentionally does not publish a fixed HIFU-to-Ultherapy price ratio or assume that a lower quote describes the same treatment scope.
Section 7 / 7
These sources do not establish Korean authorization for either device, a universal device ranking, or personal suitability. This page is an editorial evidence guide and does not record a new clinical review by a named physician.
FAQ
No. HIFU is a broad technology category. Ultherapy is a branded MFU-V platform. Compare the exact device and model, not only the category label.
No published head-to-head randomized trial establishes a universal winner across every model and protocol. Evidence and regulatory records are device-specific.
It is a model-specific US device record for the named Ulthera System. It should not be generalized to other HIFU devices, and it does not determine Korean authorization.
No. The current US IFU lists imaging from 0 to 8 mm, while its face-and-neck treatment transducers focus at 1.5, 3.0, or 4.5 mm. Imaging range and treatment focal depth are different specifications.
No. It was a single cohort with immediate pre/post three-dimensional measurements and no Ultherapy comparison group. It can inform device-specific evidence, but it cannot establish comparative superiority or durability.
Related Procedures
If you need more detail about treatment approach, recovery, or suitability, continue to these procedure pages.
Non-surgical Lifting
Ultherapy is a brand-name microfocused-ultrasound platform with imaging. Published studies report variable change in selected patients; candidate selection, anatomy, area, transducer, settings, risks, recovery, and expectations require individual assessment. It does not guarantee lifting or replace surgery.
Solta Medical · AccuREP Technology
Thermage FLX is a monopolar radiofrequency platform. Published studies report variable and generally modest tightening in selected patients; tip, area, settings, risks, recovery, and expectations require individual assessment. It does not guarantee jawline change or replace surgery or volume treatment.
Periorbital Tightening
Eye Thermage FLX in Seoul uses an eye-specific RF tip for mild eyelid laxity and fine lines. Review eye protection, risks, 25–35 min timing and downtime.
Anti-Aging Package
Neck tightening package in Seoul: Botox for platysmal bands plus filler for neck creases. Board-certified dermatologist in Gangnam.